Q3 FY2026 · ended Jul 31, 2026 · Revenue $1.07B, +0.6% YoY · Filed Sep 9, 2026
The Cooper Companies, Inc. (COO) files with the SEC under industry code 3851, Ophthalmic Goods. In Q3 of fiscal 2026, the quarter ended Jul 31, 2026, it reported revenue of $1.1 billion and net income of $432.8 million. Free cash flow was $273.0 million. As of Jul 31, 2026 it held $154.7 million in cash and investments and $3.2 billion in total debt.
Revenue
$1.07B
+0.6% vs year-ago quarter
Net income
$432.80M
+340.3% vs year-ago quarter
Operating cash flow
$341.70M
+30.7% vs year-ago quarter
Free cash flow
$273.00M
+66.0% vs year-ago quarter
EPS
$2.24
+357.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
190.16M
-4.4% vs year-ago quarter
Net cash
$-3.02B
Q3 FY2026
Operating margin
12.8%
TTM
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- COO (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- DE
- Headquarters
- San Ramon, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 711404
- Former names
- COOPER COMPANIES INC (until Jun 26, 2019)
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- Staar Surgical Co STAA
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jul 31, 2026 |
Q2 FY2026 Apr 30, 2026 |
Q1 FY2026 Jan 31, 2026 |
Q4 FY2025 Oct 31, 2025 |
Q3 FY2025 Jul 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.0B | $1.1B | $1.1B |
| Operating income | $222.0M | -$31.0M | $212.8M | $140.4M | $175.7M |
| Net income | $432.8M | -$77.9M | $130.8M | $84.6M | $98.3M |
| Diluted EPS | $2.24 | -$0.40 | $0.66 | $0.43 | $0.49 |
| Operating cash flow | $341.7M | $182.8M | $260.9M | $247.9M | $261.4M |
| Free cash flow | $273.0M | $96.4M | $158.7M | $149.9M | $164.5M |
| Total assets | $12.7B | $12.5B | $12.4B | $12.4B | $12.4B |
| Total liabilities | $4.3B | $4.2B | $4.1B | $4.2B | $4.0B |
| Stockholders' equity | $8.3B | $8.2B | $8.4B | $8.2B | $8.4B |
| Cash and investments | $154.7M | $138.8M | $124.9M | $110.6M | $124.9M |
| Total debt | $3.2B | $3.1B | $3.1B | $2.8B | $2.5B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Sep 9, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Jun 5, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Officer or director change
|
May 4, 2026 | May 4, 2026 |
All 1000 The Cooper Companies, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.